FAM114A2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.417210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.180800E-01
Normal-vs-Stage2
1.118390E-01
Normal-vs-Stage3
5.374100E-02
Normal-vs-Stage4
5.964000E-01
Stage1-vs-Stage2
1.153420E-01
Stage1-vs-Stage3
3.138100E-02
Stage1-vs-Stage4
7.816200E-01
Stage2-vs-Stage3
4.077800E-01
Stage2-vs-Stage4
3.310200E-01
Stage3-vs-Stage4
1.821450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.260840E-01
Normal-vs-AfricanAmerican
5.049000E-01
Normal-vs-Asian
6.739900E-02
Caucasian-vs-AfricanAmerican
4.979200E-01
Caucasian-vs-Asian
7.181700E-02
AfricanAmerican-vs-Asian
1.855380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.000970E-01
Normal-vs-Female
2.221600E-01
Male-vs-Female
7.355600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.289600E-01
Normal-vs-Age(41-60Yrs)
3.033400E-01
Normal-vs-Age(61-80Yrs)
1.085370E-01
Normal-vs-Age(81-100Yrs)
3.385900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.559800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.067600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.193000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.076200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.007810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.516800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.683800E-02
Normal-vs-Daily Drinker
1.782130E-02
Normal-vs-Weekly Drinker
1.518180E-01
Normal-vs-Occasional Drinker
1.962050E-01
Normal-vs-Social Drinker
4.850800E-01
Non Drinker-vs-Daily Drinker
4.986000E-01
Non Drinker-vs-Weekly Drinker
8.010400E-01
Non Drinker-vs-Occasional Drinker
4.351800E-01
Non Drinker-vs-Social Drinker
8.388100E-02
Daily Drinker-vs-Weekly Drinker
4.644200E-01
Daily Drinker-vs-Occasional Drinker
2.107800E-01
Daily Drinker-vs-Social Drinker
4.034100E-02
Weekly Drinker-vs-Occasional Drinker
7.127000E-01
Weekly Drinker-vs-Social Drinker
2.815600E-01
Occasional Drinker-vs-Social Drinker
4.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.677020E-01
Normal-vs-Grade 2
6.435800E-02
Normal-vs-Grade 3
7.937500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.669400E-01
Grade 1-vs-Grade 3
9.886400E-01
Grade 1-vs-Grade 4
1.677020E-01
Grade 2-vs-Grade 3
5.768800E-01
Grade 2-vs-Grade 4
6.435800E-02
Grade 3-vs-Grade 4
7.937500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.339970E-01
Normal-vs-NonDiabetic
7.573600E-02
Diabetic-vs-NonDiabetic
7.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.980330E-02
Normal-vs-NoPancreatitis
1.164390E-01
Pancreatitis-vs-NoPancreatitis
2.752600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.711800E-01
Normal-vs-N1
1.042970E-01
N0-vs-N1
4.444400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.422200E-02
Normal-vs-TP53-NonMutant
4.283200E-01
TP53-Mutant-vs-TP53-NonMutant
1.346090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
